Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

ENETS Abstract Search

#4203 The diagnostic role of DWI-MRI for liver metastases of neuroendocrine neoplasms (NENs) in comparison with the functional imaging

Introduction: A combination of morphological and functional imaging plays a crucial role for diagnosis, staging and therapeutic decision for neuroendocrine neoplasms (NENs). Diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) is emerging as a key imaging technique in the NEN field.

Conference:

Presenting Author: Sesti F

Authors: Feola T, Sesti F, Centello R, Filice A, Pirisino R,

Keywords: MRI, DWI, PET, Liver metastases,

#4044 18 F-DOPA PET/CT leading to diagnosis of micro pheochromocytoma

Introduction: Pheochromocytomas are rare neuroendocrine tumors arising from the chromaffin cells of the adrenal medulla. The recent revision in the WHO classification of Endocrine Tumors 2022 has replaced the historical term "nodular hyperplasia" with "micro pheochromocytoma," owing to the presence of similar molecular clonal changes as larger tumors.

Conference:

Presenting Author:

Authors: Roman-Gonzalez A, Arias L, Castellano A, Toro J, Vega I,

Keywords: Pheochromocytoma, PET-CT, Paraganglioma, NGS,

#3943 A case of conversion therapy for pancreatic neuroendocrine tumor with liver metastasis using Surufatinib combined with CAPTEM

Introduction: The preferred treatment for p-NETs is radical surgical resection. To increase the possibility of R0 resection, clinicians have been interested in conversion therapy which induces the tumor regression. However, no prospective studies have revealed which patients and p-NETs subcategory are suitable for conversion therapy and the best conversion therapy project.

Conference:

Presenting Author: Wang Z

Authors: Xie Z, Wang Z, Cao D, Ke N,

Keywords: p-NETs, conversion therapy, surufatinib, CAPTEM,

#3920 Complete and sustained response after peptide receptor radionuclide therapy in a 66-year-old Filipino male with metastatic pancreatic neuroendocrine tumor: A case report primary

Introduction: The introduction of peptide receptor radionuclide therapy (PRRT) to the Philippines has allowed for novel approaches in the management of neuroendocrine tumors (NETs).

Conference:

Presenting Author: Chianpian C

Authors: Chianpian C, Bautista-Peñalosa P, Santos C, Bandong I,

Keywords: peptide receptor radionuclide therapy, metastatic pancreatic neuroendocrine tumor, Ga-68 DOTATATE, Lu-177 DOTATATE, Philippines,

#3809 Metastatic pattern and its prognostic value in well-differentiated neuroendocrine tumors

Introduction: The metastatic pattern of neuroendocrine tumors (NETs) and its potential prognostic value has not been well elucidated.

Conference:

Presenting Author:

Authors: Chen L, Yan X, Liu M, Lin Y, He Q,

Keywords: neuroendocrine tumor, metastasis, progression,